rs397517071
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PP3PP5
The NM_005159.5(ACTC1):c.806T>C(p.Ile269Thr) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005159.5 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
The I269T variant in the ACTC1 gene has not been reported previously as a disease-causing mutation or as a benign polymorphism to our knowledge, but this variant has been observed in other unrelated individuals tested for DCM I269T results in a non-conservative amino acid substitution of a non-polar Isoleucine with a neutral, polar Threonine. While the Ile269 residue is not uniformly conserved across species, variation is limited to other non-polar amino acids at this position. In silico analysis predicts I269T is damaging to the protein structure/function. Mutations in nearby residues (M271V, S273F) have been reported in association with cardiomyopathy, supporting the functional importance of this region of the protein. Furthermore, I269T was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, I269T is a good candidate for a disease-causing mutation. -
PP2, PP3, PM2, PS4_moderate -
- -
Primary dilated cardiomyopathy;C1960469:Left ventricular noncompaction Pathogenic:1
The p.Ile269Thr variant has been identified in 3 individuals with early-onset ca rdiomyopathy and segregated with disease in 5 affected family members from 2 fam ilies (GeneDx pers. comm., LMM data). Phenotypes of these individuals included D CM, LVNC, and HCM. Severity in affected family members was variable raising the possibility that other genetic or environmental factors were present in the earl y onset cases. The p.Ile269Thr variant was absent from large population studies but has been reported in ClinVar (Variation ID# 45190). Computational prediction tools and conservation analysis suggest that the p.Ile269Thr variant may impact the protein, though this information is not predictive enough to determine path ogenicity. In summary, although additional studies are required to fully establi sh its clinical significance, the p.Ile269Thr variant is likely pathogenic. ACMG /AMP Criteria applied: PM2; PP1_Moderate; PP3; PS4_Supporting. -
Hypertrophic cardiomyopathy 11;C2748552:Atrial septal defect 5;C3150681:Dilated cardiomyopathy 1R Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). ClinVar contains an entry for this variant (Variation ID: 45190). This missense change has been observed in individual(s) with clinical features of ACTC1-related conditions (PMID: 24503780). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 269 of the ACTC1 protein (p.Ile269Thr). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at